Search - tctmd.com

$TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...$

Presentation TCT 2012

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Presenter: Lamin King

October 23, 2012

Advertisement

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

ULTIMA: Ultrasound Accelerated Thrombolysis Shows Promise for Pulmonary Embolism

Radial, Femoral PCI Show Similar Bleeding Rates in NSTE ACS Patients

Las PCI Radiales y Femorales arrojan Índices Hemorrágicos Similares en Pacientes víctimas de SCA NSTE

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

El ROCKET AF Analiza el Riesgo de ACV tras Interrumpir la Anticoagulación

Heparin Versus Bivalirudin– In-hospital And 30 Day MACE In Patients Having DES Implantation

Meta-Analysis Finds No Clear Answer for Same-Day Discharge After PCI

Un Meta Análisis No Aclara la Cuestión del Alta Hospitalaria el Mismo Día de Realizar una PCI

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Carta de JACC: La Terapia Hipotérmica podría Aumentar el Riesgo de Trombosis del Stent

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

Procedural, Spontaneous MI Carry Different Prognostic Weights

Los IM Operatorios y Espontáneos Diferentes Pronósticos

STEMI-RADIAL Radial PCI Bests Femoral in STEMI Patients

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

TCT-50. Influence of Age on Clinical Outcomes in Patients with NSTEMI Undergoing Treatment with Abciximab plus Unfractionated Heparin vs. Bivalirudin: Analysis of the ISAR...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content